{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:42:16Z","timestamp":1790800936424,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":75,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783662463437","type":"print"},{"value":"9783662463444","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/7854_2014_317","type":"book-chapter","created":{"date-parts":[[2014,5,21]],"date-time":"2014-05-21T03:57:16Z","timestamp":1400644636000},"page":"205-220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":115,"title":["Clinical and Pathological Features of Parkinson\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Susanne A.","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Obeso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,22]]},"reference":[{"issue":"1","key":"317_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrneurol.2011.189","volume":"8","author":"D Aarsland","year":"2012","unstructured":"Aarsland D, Pahlhagen S, Ballard CG, Ehrt U, Svenningsson P (2012) Depression in Parkinson disease\u2013epidemiology, mechanisms and management. Nat Rev Neurol 8(1):35\u201347","journal-title":"Nat Rev Neurol"},{"key":"317_CR2","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/mds.25090","volume":"27","author":"M Alegre","year":"2012","unstructured":"Alegre M, L\u00f3pez-Azc\u00e1rate J, Alonso-Frech F, Rodr\u00edguez-Oroz MC, Valencia M, Guridi J, Artieda J, Obeso JA (2012) Subthalamic activity during diphasic dyskinesias in Parkinson\u2019s disease. Mov Disord 27:1178\u20131181","journal-title":"Mov Disord"},{"key":"317_CR3","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1093\/brain\/awl103","volume":"129","author":"F Alonso-Frech","year":"2006","unstructured":"Alonso-Frech F, Zamarbide I, Alegre M, Rodr\u00edguez-Oroz MC, Guridi J, Manrique M, Valencia M, Artieda J, Obeso JA (2006) Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson\u2019s disease. Brain 129:1748\u20131757","journal-title":"Brain"},{"key":"317_CR4","doi-asserted-by":"crossref","unstructured":"Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, et al, PRIAMO study group (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson\u2019s disease. Mov Disord 24(11):1641\u20131649","DOI":"10.1002\/mds.22643"},{"issue":"8","key":"317_CR5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3109\/07853890.2013.849003","volume":"45","author":"MS Beavan","year":"2013","unstructured":"Beavan MS, Schapira AH (2013) Glucocerebrosidase mutations and the pathogenesis of Parkinson disease. Ann Med 45(8):511\u2013521","journal-title":"Ann Med"},{"issue":"1","key":"317_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/ene.12022","volume":"20","author":"A Berardelli","year":"2013","unstructured":"Berardelli A, Wenning GK, Antonini A, Berg D, Bloem BR, Bonifati V et al (2013) EFNS\/MDS-ES recommendations for the diagnosis of Parkinson\u2019s disease. Eur J Neurol 20(1):16\u201334","journal-title":"Eur J Neurol"},{"key":"317_CR7","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1212\/WNL.0b013e3181b0bd3d","volume":"73","author":"NI Bohnen","year":"2009","unstructured":"Bohnen NI, Albin RL (2009) Cholinergic denervation occurs early in Parkinson disease. Neurology 73:256\u2013257","journal-title":"Neurology"},{"issue":"Suppl 1","key":"317_CR8","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/S1353-8020(11)70004-9","volume":"18","author":"V Bonifati","year":"2012","unstructured":"Bonifati V (2012) Autosomal recessive Parkinsonism. Parkinsonism Relat Disord 18(Suppl 1):S4\u2013S6","journal-title":"Parkinsonism Relat Disord"},{"key":"317_CR9","doi-asserted-by":"crossref","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24(2):197\u2013211","DOI":"10.1016\/S0197-4580(02)00065-9"},{"issue":"4","key":"317_CR10","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.pneurobio.2011.08.009","volume":"95","author":"DJ Brooks","year":"2011","unstructured":"Brooks DJ, Pavese N (2011) Imaging biomarkers in Parkinson\u2019s disease. Prog Neurobiol 95(4):614\u2013628","journal-title":"Prog Neurobiol"},{"issue":"5","key":"317_CR11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/ana.21541","volume":"64","author":"RE Burke","year":"2008","unstructured":"Burke RE, Dauer WT, Vonsattel JP (2008) A critical evaluation of the Braak staging scheme for Parkinson\u2019s disease. Ann Neurol 64(5):485\u2013491","journal-title":"Ann Neurol"},{"issue":"2","key":"317_CR12","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1471-4159.2006.04124.x","volume":"99","author":"MA Cenci","year":"2006","unstructured":"Cenci MA, Lundblad M (2006) Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia. J Neurochem 99(2):381\u2013392","journal-title":"J Neurochem"},{"issue":"6","key":"317_CR13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.2174\/187152711797247885","volume":"10","author":"MA Cenci","year":"2011","unstructured":"Cenci MA, Ohlin KE, Odin P (2011) Current options and future possibilities for the treatment of dyskinesia and motor fluctuations in Parkinson\u2019s disease. CNS Neurol Disord Drug Targets 10(6):670\u2013684","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"317_CR14","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/brain\/awr031","volume":"134","author":"Y Compta","year":"2011","unstructured":"Compta Y, Parkkinen L, O\u2019Sullivan SS, Vandrovcova J, Holton JL, Collins C, Lashley T, Kallis C, Williams DR, de Silva R, Lees AJ, Revesz T (2011) Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: which is more important? Brain 134:1493\u20131505","journal-title":"Brain"},{"key":"317_CR15","doi-asserted-by":"crossref","unstructured":"Derkinderen P, Rouaud T, Lebouvier T, Bruley des Varannes S, Neunlist M, De Giorgio R (2011) Parkinson disease: the enteric nervous system spills its guts. Neurology 77(19):1761\u20131767","DOI":"10.1212\/WNL.0b013e318236ef60"},{"issue":"1\u20132","key":"317_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jns.2011.10.025","volume":"314","author":"NJ Diederich","year":"2012","unstructured":"Diederich NJ, McIntyre DJ (2012) Sleep disorders in Parkinson\u2019s disease: many causes, few therapeutic options. J Neurol Sci 314(1\u20132):12\u201319","journal-title":"J Neurol Sci"},{"key":"317_CR17","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780192619112.001.0001","volume-title":"Marsden\u2019s book of movement disorders","author":"I Donaldson","year":"2012","unstructured":"Donaldson I, Marsden CD, Schneider S, Bhatia K (2012) Marsden\u2019s book of movement disorders. Oxford University Press, Oxford"},{"key":"317_CR18","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey ER, Constantinescu R, Thompson JP, Biglan K, Holloway RG, Kieburtz K, Marshall FJ, Ravina B, Schifitto G, Siderowf A, Tanner C (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68:384\u2013386","journal-title":"Neurology"},{"issue":"3","key":"317_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.nbd.2011.10.026","volume":"46","author":"RL Doty","year":"2012","unstructured":"Doty RL (2012) Olfaction in Parkinson\u2019s disease and related disorders. Neurobiol Dis 46(3):527\u2013552","journal-title":"Neurobiol Dis"},{"issue":"4","key":"317_CR20","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1212\/WNL.42.4.726","volume":"42","author":"LL Edwards","year":"1992","unstructured":"Edwards LL, Quigley EM, Pfeiffer RF (1992) Gastrointestinal dysfunction in Parkinson\u2019s disease: frequency and pathophysiology. Neurology 42(4):726\u2013732","journal-title":"Neurology"},{"issue":"Pt 5","key":"317_CR21","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley JM, Lees AJ (1991) Ageing Parkinson\u2019s disease: Substantia nigra regional selectivity. Brain 114(Pt 5):2283\u20132301","journal-title":"Brain"},{"issue":"2","key":"317_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.parkreldis.2008.04.038","volume":"15","author":"PG Frisina","year":"2009","unstructured":"Frisina PG, Haroutunian V, Libow LS (2009) The neuropathological basis for depression in Parkinson\u2019s disease. Parkinsonism Relat Disord 15(2):144\u2013148","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"317_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1053\/smrv.2002.0229","volume":"7","author":"D Garcia-Borreguero","year":"2003","unstructured":"Garcia-Borreguero D, Larrosa O, Bravo M (2003) Parkinson\u2019s disease and sleep. Sleep Med Rev 7(2):115\u2013129","journal-title":"Sleep Med Rev"},{"key":"317_CR24","first-page":"3","volume":"183","author":"T Gasser","year":"2010","unstructured":"Gasser T (2010) Identifying PD-causing genes and genetic susceptibility factors: current approaches and future prospects. Prog Brain Res 183:3\u201320","journal-title":"Prog Brain Res"},{"key":"317_CR25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1468-1331.2007.01727.x","volume":"14","author":"M Guttman","year":"2007","unstructured":"Guttman M, Boileau I, Warsh J, Saint-Cyr JA, Ginovart N, McCluskey T, Houle S, Wilson A, Mundo E, Rusjan P, Meyer J, Kish SJ (2007) Brain serotonin transporter binding in non-depressed patients with Parkinson\u2019s disease. Eur J Neurol 14:523\u2013528","journal-title":"Eur J Neurol"},{"issue":"6","key":"317_CR26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1586\/ern.12.47","volume":"12","author":"G Halliday","year":"2012","unstructured":"Halliday G, McCann H, Shepherd C (2012) Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson\u2019s disease? Expert Rev Neurother 12(6):673\u2013686","journal-title":"Expert Rev Neurother"},{"issue":"6","key":"317_CR27","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20\u00a0years. Mov Disord 23(6):837\u2013844","journal-title":"Mov Disord"},{"issue":"1","key":"317_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/mds.23795","volume":"27","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA (2012) Neuropathology of sporadic Parkinson\u2019s disease: evaluation and changes of concepts. Mov Disord 27(1):8\u201330","journal-title":"Mov Disord"},{"issue":"20","key":"317_CR30","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.2169\/internalmedicine.50.5935","volume":"50","author":"K Kashihara","year":"2011","unstructured":"Kashihara K, Hanaoka A, Imamura T (2011) Frequency and characteristics of taste impairment in patients with Parkinson\u2019s disease: results of a clinical interview. Int Med 50(20):2311\u20132315","journal-title":"Int Med"},{"issue":"4","key":"317_CR31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/01.wco.0000137531.76491.c2","volume":"17","author":"R Katzenschlager","year":"2004","unstructured":"Katzenschlager R, Lees AJ (2004) Olfaction and Parkinson\u2019s syndromes: its role in differential diagnosis. Curr Opin Neurol 17(4):417\u2013423","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"317_CR32","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1007\/s00415-010-5884-x","volume":"258","author":"HJ Kim","year":"2011","unstructured":"Kim HJ, Jeon BS, Lee JY, Cho YJ, Hong KS, Cho JY (2011) Taste function in patients with Parkinson disease. J Neurol 258(6):1076\u20131079","journal-title":"J Neurol"},{"key":"317_CR33","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","volume":"136","author":"JH Kordower","year":"2013","unstructured":"Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, Halliday GM, Bartus RT (2013) Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease. Brain 136:2419\u20132431","journal-title":"Brain"},{"issue":"9680","key":"317_CR34","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees AJ, Hardy J, Revesz T (2009) Parkinson\u2019s disease. Lancet 373(9680):2055\u20132066","journal-title":"Lancet"},{"key":"317_CR35","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1136\/jnnp.2003.033530","volume":"76","author":"SJ Lewis","year":"2005","unstructured":"Lewis SJ, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA (2005) Heterogeneity of Parkinson\u2019s disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry 76:343\u2013348","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"317_CR36","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/mds.10459","volume":"18","author":"I Litvan","year":"2003","unstructured":"Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I et al (2003) Movement disorders society scientific issues committee. Movement disorders society scientific issues committee report: SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18(5):467\u2013486","journal-title":"Mov Disord"},{"issue":"11","key":"317_CR37","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s00702-009-0274-1","volume":"116","author":"M L\u00f6hle","year":"2009","unstructured":"L\u00f6hle M, Storch A, Reichmann H (2009) Beyond tremor and rigidity: non-motor features of Parkinson\u2019s disease. J Neural Transm 116(11):1483\u20131492","journal-title":"J Neural Transm"},{"issue":"1","key":"317_CR38","first-page":"141","volume":"47","author":"AM Lozano","year":"2000","unstructured":"Lozano AM (2000) Neuronal recordings in Parkinson\u2019s disease patients with dyskinesias induced by apomorphine. Ann Neurol 47(1):141\u2013146","journal-title":"Ann Neurol"},{"issue":"12","key":"317_CR39","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/S1474-4422(09)70291-1","volume":"8","author":"W Maetzler","year":"2009","unstructured":"Maetzler W, Liepelt I, Berg D (2009) Progression of Parkinson\u2019s disease in the clinical phase: potential markers. Lancet Neurol 8(12):1158\u20131171","journal-title":"Lancet Neurol"},{"issue":"3","key":"317_CR40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3233\/JPD-2012-120103","volume":"2","author":"A Manson","year":"2012","unstructured":"Manson A, Stirpe P, Schrag A (2012) Levodopa-induced-dyskinesias clinical features, incidence, risk factors, management and impact on quality of life. J Parkinsons Dis 2(3):189\u2013198","journal-title":"J Parkinsons Dis"},{"issue":"11","key":"317_CR41","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/mds.21586","volume":"22","author":"P Martinez-Martin","year":"2007","unstructured":"Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, MacPhee G, Brown RG, Naidu Y, Clayton L, Abe K, Tsuboi Y, MacMahon D, Barone P, Rabey M, Bonuccelli U, Forbes A, Breen K, Tluk S, Olanow CW, Thomas S, Rye D, Hand A, Williams AJ, Ondo W, Chaudhuri KR (2007) Prevalence of nonmotor symptoms in Parkinson\u2019s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 22(11):1623\u20131629","journal-title":"Mov Disord"},{"issue":"3","key":"317_CR42","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.parkreldis.2007.08.003","volume":"14","author":"AC Nobrega","year":"2008","unstructured":"Nobrega AC, Rodrigues B, Torres AC, Scarpel RD, Neves CA, Melo A (2008) Is drooling secondary to a swallowing disorder in patients with Parkinson\u2019s disease? Parkinsonism Relat Disord 14(3):243\u2013245","journal-title":"Parkinsonism Relat Disord"},{"key":"317_CR43","first-page":"51","volume":"17","author":"JA Obeso","year":"2002","unstructured":"Obeso JA, Rodr\u00edguez-Oroz MC, Rodr\u00edguez M, Arbizu J, Gim\u00e9nez-Amaya JM (2002) The basal ganglia and disorders of movement: pathophysiological mechanisms. News Physiol Sci 17:51\u201355","journal-title":"News Physiol Sci"},{"key":"317_CR44","doi-asserted-by":"crossref","unstructured":"Olanow WC, Kieburtz K, Rascol O, Poewe W, Schapira AH, Emre M, Nissinen H, Leinonen M, Stocchi F, Stalevo Reduction in Dyskinesia Evaluation in Parkinson\u2019s Disease (STRIDE-PD) Investigators (2013) Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson\u2019s disease. Mov Disord 28(8):1064\u20131071","DOI":"10.1002\/mds.25364"},{"key":"317_CR45","doi-asserted-by":"crossref","unstructured":"Ondo (2011) Motor complications in Parkinson\u2019s disease. Int J Neurosci 121:37\u201344","DOI":"10.3109\/00207454.2011.620198"},{"issue":"3","key":"317_CR46","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.nbd.2012.03.029","volume":"46","author":"J Pagonabarraga","year":"2012","unstructured":"Pagonabarraga J, Kulisevsky J (2012) Cognitive impairment and dementia in Parkinson\u2019s disease. Neurobiol Dis 46(3):590\u2013596","journal-title":"Neurobiol Dis"},{"key":"317_CR47","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/srep00898","volume":"2","author":"F Pan-Montojo","year":"2012","unstructured":"Pan-Montojo F, Schwarz M, Winkler C, Arnhold M, O\u2019Sullivan GA, Pal A, Said J, Marsico G, Verbavatz JM, Rodrigo-Angulo M, Gille G, Funk RH, Reichmann H (2012) Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci Rep 2:898","journal-title":"Sci Rep"},{"issue":"6","key":"317_CR48","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1097\/00005072-199111000-00006","volume":"50","author":"W Paulus","year":"1991","unstructured":"Paulus W, Jellinger K (1991) The neuropathologic basis of different clinical subgroups of Parkinson\u2019s disease. J Neuropathol Exp Neurol 50(6):743\u2013755","journal-title":"J Neuropathol Exp Neurol"},{"key":"317_CR49","doi-asserted-by":"crossref","unstructured":"Poewe W (2009) Clinical measures of progression in Parkinson\u2019s disease. Mov Disord 24(2):S671\u2013S676","DOI":"10.1002\/mds.22600"},{"issue":"21","key":"317_CR50","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1212\/WNL.0b013e3181feb2ab","volume":"75","author":"M Politis","year":"2010","unstructured":"Politis M, Wu K, Loane C, Turkheimer FE, Molloy S, Brooks DJ, Piccini P (2010) Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology 75(21):1920\u20131927","journal-title":"Neurology"},{"issue":"Suppl 1","key":"317_CR51","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S1353-8020(13)00400-8","volume":"20","author":"RB Postuma","year":"2014","unstructured":"Postuma RB (2014) Prodromal Parkinson\u2019s disease\u2013using REM sleep behavior disorder as a window. Parkinsonism Relat Disord 20(Suppl 1):S1\u2013S4","journal-title":"Parkinsonism Relat Disord"},{"key":"317_CR52","doi-asserted-by":"crossref","unstructured":"Pouclet H, Lebouvier T, Coron E, des Varannes SB, Rouaud T, Roy M, Neunlist M, Derkinderen P (2012) A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson\u2019s disease. Neurobiol Dis. 45(1):305\u2013309","DOI":"10.1016\/j.nbd.2011.08.014"},{"issue":"3","key":"317_CR53","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1515\/revneuro-2013-0002","volume":"24","author":"A Raggi","year":"2013","unstructured":"Raggi A, Bella R, Pennisi G, Neri W, Ferri R (2013) Sleep disorders in Parkinson\u2019s disease: a narrative review of the literature. Rev Neurosci 24(3):279\u2013291","journal-title":"Rev Neurosci"},{"issue":"Pt 6","key":"317_CR54","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/brain\/awh445","volume":"128","author":"P Remy","year":"2005","unstructured":"Remy P, Doder M, Lees A, Turjanski N, Brooks D (2005) Depression in Parkinson\u2019s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128(Pt 6):1314\u20131322","journal-title":"Brain"},{"issue":"3","key":"317_CR55","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/mds.870110304","volume":"11","author":"RA Roos","year":"1996","unstructured":"Roos RA, Jongen JC, van der Velde EA (1996) Clinical course of patients with idiopathic Parkinson\u2019s disease. Mov Disord 11(3):236\u2013242","journal-title":"Mov Disord"},{"issue":"1","key":"317_CR56","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/mds.22519","volume":"25","author":"R Sakakibara","year":"2010","unstructured":"Sakakibara R, Uchiyama T, Yamanishi T, Kishi M (2010) Genitourinary dysfunction in Parkinson\u2019s disease. Mov Disord 25(1):2\u201312","journal-title":"Mov Disord"},{"key":"317_CR57","doi-asserted-by":"crossref","unstructured":"Sato K, Hatano T, Yamashiro K, Kagohashi M, Nishioka K, Izawa N et al, Juntendo Parkinson Study Group (2006) Prognosis of Parkinson\u2019s disease: time to stage III, IV, V, and to motor fluctuations. Mov Disord 21(9):1384\u20131395","DOI":"10.1002\/mds.20993"},{"key":"317_CR100","unstructured":"Schneider SA, Alexoudi A, B\u00f6ttner M, et al Can we use peripheral tissue biopsies to diagnose Parkinson\u00b4s disease? A review of the literature (in preparation)"},{"key":"317_CR58","doi-asserted-by":"crossref","unstructured":"Selikhova M, Williams DR, Kempster PA, Holton JL, Revesz T, Lees AJ (2009) A clinico-pathological study of subtypes in Parkinson\u2019s disease. Brain 132:2947\u20132957","DOI":"10.1093\/brain\/awp234"},{"issue":"3","key":"317_CR59","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.parkreldis.2008.05.008","volume":"15","author":"M Shah","year":"2009","unstructured":"Shah M, Deeb J, Fernando M, Noyce A, Visentin E, Findley LJ, Hawkes CH (2009) Abnormality of taste and smell in Parkinson\u2019s disease. Parkinsonism Relat Disord 15(3):232\u2013237","journal-title":"Parkinsonism Relat Disord"},{"key":"317_CR60","doi-asserted-by":"crossref","unstructured":"Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH (2012) Is alpha-synuclein in the colon a biomarker for premotor Parkinson\u2019s disease? Evidence from 3 cases.Mov Disord 27(6):716\u2013719","DOI":"10.1002\/mds.25020"},{"issue":"11","key":"317_CR61","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","volume":"11","author":"E Sidransky","year":"2012","unstructured":"Sidransky E, Lopez G (2012) The link between the GBA gene and parkinsonism. Lancet Neurol 11(11):986\u2013998","journal-title":"Lancet Neurol"},{"issue":"4","key":"317_CR62","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/RHU.0b013e3181826d43","volume":"14","author":"W Stamey","year":"2008","unstructured":"Stamey W, Davidson A, Jankovic J (2008) Shoulder pain: a presenting symptom of Parkinson disease. J Clin Rheumatol 14(4):253\u2013254","journal-title":"J Clin Rheumatol"},{"issue":"15","key":"317_CR63","doi-asserted-by":"publisher","first-page":"10736","DOI":"10.1074\/jbc.R112.410530","volume":"288","author":"DJ Surmeier","year":"2013","unstructured":"Surmeier DJ, Schumacker PT (2013) Calcium, bioenergetics, and neuronal vulnerability in Parkinson\u2019s disease. J Biol Chem 288(15):10736\u201310741","journal-title":"J Biol Chem"},{"issue":"8","key":"317_CR64","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S1474-4422(12)70152-7","volume":"11","author":"P Svenningsson","year":"2012","unstructured":"Svenningsson P, Westman E, Ballard C, Aarsland D (2012) Cognitive impairment in patients with Parkinson\u2019s disease: diagnosis, biomarkers, and treatment. Lancet Neurol 11(8):697\u2013707","journal-title":"Lancet Neurol"},{"issue":"980","key":"317_CR65","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/pgmj.2006.054759","volume":"83","author":"B Thanvi","year":"2007","unstructured":"Thanvi B, Lo N, Robinson T (2007) Levodopa-induced dyskinesia in Parkinson\u2019s disease: clinical features, pathogenesis, prevention and treatment. Postgrad Med J 83(980):384\u2013388","journal-title":"Postgrad Med J"},{"issue":"6","key":"317_CR66","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1586\/ern.09.50","volume":"9","author":"DD Truong","year":"2009","unstructured":"Truong DD, Wolters EC (2009) Recognition and management of Parkinson\u2019s disease during the premotor (prodromal) phase. Expert Rev Neurother 9(6):847\u2013857","journal-title":"Expert Rev Neurother"},{"issue":"8","key":"317_CR67","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/mds.23116","volume":"25","author":"SM van Rooden","year":"2010","unstructured":"van Rooden SM, Heiser WJ, Kok JN, Verbaan D, van Hilten JJ, Marinus J (2010) The identification of Parkinson\u2019s disease subtypes using cluster analysis: a systematic review. Mov Disord 25(8):969\u2013978","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"317_CR68","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1016\/S1353-8020(11)70026-8","volume":"18","author":"D Vilas","year":"2012","unstructured":"Vilas D, Pont-Sunyer C, Tolosa E (2012) Impulse control disorders in Parkinson\u2019s disease. Parkinsonism Relat Disord 18(Suppl 1):S80\u2013S84","journal-title":"Parkinsonism Relat Disord"},{"key":"317_CR69","doi-asserted-by":"crossref","unstructured":"Visanji NP, Brooks PL, Hazrati LN, Lang AE (2013) The prion hypothesis in Parkinson's disease: braak to the future. Acta Neuropathol Commun 1(1):2","DOI":"10.1186\/2051-5960-1-2"},{"key":"317_CR70","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/S1474-4422(09)70287-X","volume":"8","author":"V Voon","year":"2009","unstructured":"Voon V, Fernagut PO, Wickens J, Baunez C, Rodriguez M, Pavon N, Juncos JL, Obeso JA, Bezard E (2009) Chronic dopaminergic stimulation in Parkinson\u2019s disease: from dyskinesias to impulse control disorders. Lancet Neurol 8:1140\u20131149","journal-title":"Lancet Neurol"},{"issue":"6","key":"317_CR71","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/mds.20867","volume":"21","author":"K Winge","year":"2006","unstructured":"Winge K, Fowler CJ (2006) Bladder dysfunction in Parkinsonism: mechanisms, prevalence, symptoms, and management. Mov Disord 21(6):737\u2013745","journal-title":"Mov Disord"},{"issue":"Suppl 3","key":"317_CR72","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/S1353-8020(09)70770-9","volume":"15","author":"ECh Wolters","year":"2009","unstructured":"Wolters ECh (2009) Non-motor extranigral signs and symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord 15(Suppl 3):S6\u2013S12","journal-title":"Parkinsonism Relat Disord"},{"key":"317_CR73","first-page":"309","volume":"70","author":"ECh Wolters","year":"2006","unstructured":"Wolters ECh, Braak H (2006) Parkinson\u2019s disease: premotor clinico-pathological correlations. J Neural Transm Suppl 70:309\u2013319","journal-title":"J Neural Transm Suppl"},{"key":"317_CR74","unstructured":"Schneider SA, Alexoudi A, Boettner M, Deuschl G, Wedel T (in prep) Can we use peripheral tissue biopsies to diagnose Parkinson\u00b4s disease? A review of the literature"},{"issue":"2","key":"317_CR75","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11255-011-9969-y","volume":"44","author":"L Yeo","year":"2012","unstructured":"Yeo L, Singh R, Gundeti M, Barua JM, Masood J (2012) Urinary tract dysfunction in Parkinson\u2019s disease: a review. Int Urol Nephrol 44(2):415\u2013424","journal-title":"Int Urol Nephrol"}],"container-title":["Current Topics in Behavioral Neurosciences","Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2014_317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T17:21:20Z","timestamp":1676395280000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/7854_2014_317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9783662463437","9783662463444"],"references-count":75,"URL":"https:\/\/doi.org\/10.1007\/7854_2014_317","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"22 May 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}